Notice2026-06667
Agency Forms Undergoing Paperwork Reduction Act Review
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
April 7, 2026
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Full Text
<html>
<head>
<title>Federal Register, Volume 91 Issue 66 (Tuesday, April 7, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 66 (Tuesday, April 7, 2026)]
[Notices]
[Pages 17656-17657]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-06667]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-26-0004]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``National Disease Surveillance Program II--
Disease Summaries'' to the Office of Management and Budget (OMB) for
review and approval. CDC previously published a ``Proposed Data
Collection Submitted for Public Comment and Recommendations'' notice on
January 13, 2026 to obtain comments from the public and affected
agencies. CDC received one comment related to the previous notice. This
notice serves to allow an additional 30 days for public and affected
agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
National Disease Surveillance Program II. Disease Summaries (OMB
Control No. 0920-0004, Exp. 4/30/2026)--Revision--National Center for
Immunization and Respiratory Diseases (NCIRD), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
CDC requests a three-year approval for a Revision with minimal
modifications of the National Disease Surveillance Program II. Disease
Summaries (OMB Control No. 0920-0004) information collection. As with
previous approvals, these data are essential for measuring trends in
diseases, evaluating the effectiveness of current preventive
strategies, and determining the need to modify current preventive
measures. Diseases included in this surveillance program are Influenza
Virus, Caliciviruses, Respiratory and Enteric Viruses, Enteroviruses,
Adenoviruses, Arthropod-Borne Diseases (Non-Human Data), and Pediatric
Hepatitis of Unknown Etiology. Data will be used to determine the
prevalence of disease and planning and evaluating programs for
prevention and control of infectious diseases. Disease incidence is
needed to study present and emerging disease problems.
The request for an Revision with minimal modifications includes: 11
Influenza forms, Suspect Respiratory Virus Patient Form, Middle East
Respiratory Syndrome Coronavirus (MERS) Patient Under Investigation
(PUI) Form, Viral Gastroenteritis Outbreak Submission Form, National
Respiratory and Enteric Virus Surveillance System (NREVSS) Laboratory
Assessment and National Enterovirus Surveillance Report, National
Adenovirus Type Reporting System (NATRS) Form, Pediatric Hepatitis of
Unknown Etiology Medical Record Abstraction Form (CRF) and Pediatric
Hepatitis of Unknown Etiology Medical Record Abstraction short form
version, and Arthropod (Vector)-Borne Diseases (Non-Human Data). These
forms will have minor edits with very little burden change from last
OMB approval. The data from these forms will enable rapid detection and
characterization of outbreaks of known pathogens, as well as potential
newly emerging viral pathogens.
CDC requests OMB approval for an estimated 27,517 annual burden
hours. There is no cost to respondents other than their time to
participate.
[[Page 17657]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response
respondents respondent (in hr)
----------------------------------------------------------------------------------------------------------------
Epidemiologist..................... U.S. Collaborating center 47 52 10/60
for Influenza--Influenza
Virus Surveillance.
Epidemiologist..................... U.S. Collaborating 113 1 10/60
Laboratories Influenza
Testing Methods Assessment.
Epidemiologist..................... U.S. Outpatient Influenza- 1,800 52 10/60
like Illness Surveillance
Network (ILINet)
Workfolder 55.20E.
Epidemiologist..................... Influenza-Associated 57 3 30/60
Pediatric Mortality--Case
Report Form.
Epidemiologist..................... Human Infection with Novel 57 2 30/60
Influenza A Virus Case
Report Form.
Epidemiologist..................... Human Infection with Novel 57 1 90/60
Influenza A Virus Severe
Outcomes.
Epidemiologist..................... Novel Influenza A Virus 57 1 15/60
Case Screening Form.
Epidemiologist..................... Antiviral Resistant 57 3 30/60
Influenza Infection Case
Report Form.
Epidemiologist..................... National Respiratory & 550 52 15/60
Enteric Virus Surveillance
System (NREVSS) (55.83A,
B, D) (electronic).
Epidemiologist..................... National Enterovirus 20 12 15/60
Surveillance Report: (CDC
55.9) (electronic).
Epidemiologist..................... National Adenovirus Type 13 4 15/60
Reporting System (NATRS).
Epidemiologist..................... Middle East Respiratory 57 3 25/60
Syndrome (MERS) Patient
Under Investigation (PUI)
Short Form.
Epidemiologist..................... Viral Gastroenteritis 20 5 5/60
Outbreak Submission Form.
Epidemiologist..................... Influenza Virus 64 52 5/60
(Electronic, Year Round),
PHLIP_HL7 messaging Data
Elements.
Epidemiologist..................... Influenza virus 3 52 5/60
(electronic, year round)
(PHIN-MS).
Epidemiologist..................... Suspect Respiratory Virus 10 5 30/60
Patient Form.
Epidemiologist..................... Aggregate counts of persons 52 52 10/60
exposed to Highly
Pathogenic Avian Influenza
(HPAI).
Epidemiologist..................... Pediatric Hepatitis of 52 4 15/60
Unknown Etiology Medical
Record Abstraction Short
Form.
Epidemiologist..................... Pediatric Hepatitis of 52 2 45/60
Unknown Etiology Medical
Record Abstraction Form
(CRF).
Epidemiologist..................... Arthropod (Vector)-Borne 57 52 60/60
Diseases (Non-Human Data).
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2026-06667 Filed 4-6-26; 8:45 am]
BILLING CODE 4163-18-P
</pre></body>
</html>Indexed from Federal Register on April 7, 2026.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.